The effect of fibroblast growth factors and advanced glycation end-products on the intima-media complex thickness in patients with coronary heart disease and type 2 diabetes

Objective. To determine the levels of fibroblast transforming growth factor (TGF?1), basic fibroblast growth factor (?-FGF), markers of nonspecific inflammatory response (interleukin-6 (IL-6)), C-reactive protein (CRP), advanced glycation end-products (AGEs) and their receptors (RAGEs) and to study...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ekaterina Vladimirovna Ivannikova, Victor Yurievich Kalashnikov, Olga Mikhailovna Smirnova, Alexander Borisovich Kuznetsov, Anatolievich Terekhin, Alexander Viktorovich Il'in
Formato: article
Lenguaje:EN
RU
Publicado: Endocrinology Research Centre 2014
Materias:
Acceso en línea:https://doaj.org/article/b9e0cb3b58644a6e8d6dd1d79c33d463
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b9e0cb3b58644a6e8d6dd1d79c33d463
record_format dspace
spelling oai:doaj.org-article:b9e0cb3b58644a6e8d6dd1d79c33d4632021-11-14T09:00:19ZThe effect of fibroblast growth factors and advanced glycation end-products on the intima-media complex thickness in patients with coronary heart disease and type 2 diabetes2072-03512072-037810.14341/DM2014247-55https://doaj.org/article/b9e0cb3b58644a6e8d6dd1d79c33d4632014-07-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/6400https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Objective. To determine the levels of fibroblast transforming growth factor (TGF?1), basic fibroblast growth factor (?-FGF), markers of nonspecific inflammatory response (interleukin-6 (IL-6)), C-reactive protein (CRP), advanced glycation end-products (AGEs) and their receptors (RAGEs) and to study their effect on the intima-media complex (IMC) thickness in patients with coronary heart disease (CHD) and type 2 diabetes, depending on carbohydrate metabolism compensation. Materials and Methods. 37 patients with CHD underwent a general clinical examination, analysis of the carbohydrate and lipid metabolism parameters and the renal function, and also were evaluated with instrumental methods of analysis (echocardiography, coronary angiography and duplex scanning of the brachiocephalic arteries). To determine the level of the analyzed parameters, blood samples were taken from the aorta during coronary angiography and concomitantly from the cubital vein in all patients. Results. The presence of diabetes mellitus (DM) in patients with CHD was found to be associated with a more severe atherosclerotic disease of the coronary and brachiocephalic vessels. A direct correlation between the degree of stenosis and the level of fibroblast growth factors, inflammatory factors, and advanced glycation end-products was found. A direct correlation between AGE and TGF?1 and the lipid metabolism parameters was established. A statistically significant elevation of the studied parameters in the arterial and venous blood of patients with DM was revealed. Conclusion. These findings confirm the relationship between connective tissue disorders and lipid metabolism in the pathogenesis of atherosclerosis. A negative effect of hyperglycaemia on atherosclerotic changes of the vascular wall was demonstrated.Ekaterina Vladimirovna IvannikovaVictor Yurievich KalashnikovOlga Mikhailovna SmirnovaAlexander Borisovich KuznetsovAnatolievich TerekhinAlexander Viktorovich Il'inEndocrinology Research Centrearticlefibroblast growth factorsintima-media complexadvanced glycation end-productsdiabetesatherosclerosisNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 17, Iss 2, Pp 47-55 (2014)
institution DOAJ
collection DOAJ
language EN
RU
topic fibroblast growth factors
intima-media complex
advanced glycation end-products
diabetes
atherosclerosis
Nutritional diseases. Deficiency diseases
RC620-627
spellingShingle fibroblast growth factors
intima-media complex
advanced glycation end-products
diabetes
atherosclerosis
Nutritional diseases. Deficiency diseases
RC620-627
Ekaterina Vladimirovna Ivannikova
Victor Yurievich Kalashnikov
Olga Mikhailovna Smirnova
Alexander Borisovich Kuznetsov
Anatolievich Terekhin
Alexander Viktorovich Il'in
The effect of fibroblast growth factors and advanced glycation end-products on the intima-media complex thickness in patients with coronary heart disease and type 2 diabetes
description Objective. To determine the levels of fibroblast transforming growth factor (TGF?1), basic fibroblast growth factor (?-FGF), markers of nonspecific inflammatory response (interleukin-6 (IL-6)), C-reactive protein (CRP), advanced glycation end-products (AGEs) and their receptors (RAGEs) and to study their effect on the intima-media complex (IMC) thickness in patients with coronary heart disease (CHD) and type 2 diabetes, depending on carbohydrate metabolism compensation. Materials and Methods. 37 patients with CHD underwent a general clinical examination, analysis of the carbohydrate and lipid metabolism parameters and the renal function, and also were evaluated with instrumental methods of analysis (echocardiography, coronary angiography and duplex scanning of the brachiocephalic arteries). To determine the level of the analyzed parameters, blood samples were taken from the aorta during coronary angiography and concomitantly from the cubital vein in all patients. Results. The presence of diabetes mellitus (DM) in patients with CHD was found to be associated with a more severe atherosclerotic disease of the coronary and brachiocephalic vessels. A direct correlation between the degree of stenosis and the level of fibroblast growth factors, inflammatory factors, and advanced glycation end-products was found. A direct correlation between AGE and TGF?1 and the lipid metabolism parameters was established. A statistically significant elevation of the studied parameters in the arterial and venous blood of patients with DM was revealed. Conclusion. These findings confirm the relationship between connective tissue disorders and lipid metabolism in the pathogenesis of atherosclerosis. A negative effect of hyperglycaemia on atherosclerotic changes of the vascular wall was demonstrated.
format article
author Ekaterina Vladimirovna Ivannikova
Victor Yurievich Kalashnikov
Olga Mikhailovna Smirnova
Alexander Borisovich Kuznetsov
Anatolievich Terekhin
Alexander Viktorovich Il'in
author_facet Ekaterina Vladimirovna Ivannikova
Victor Yurievich Kalashnikov
Olga Mikhailovna Smirnova
Alexander Borisovich Kuznetsov
Anatolievich Terekhin
Alexander Viktorovich Il'in
author_sort Ekaterina Vladimirovna Ivannikova
title The effect of fibroblast growth factors and advanced glycation end-products on the intima-media complex thickness in patients with coronary heart disease and type 2 diabetes
title_short The effect of fibroblast growth factors and advanced glycation end-products on the intima-media complex thickness in patients with coronary heart disease and type 2 diabetes
title_full The effect of fibroblast growth factors and advanced glycation end-products on the intima-media complex thickness in patients with coronary heart disease and type 2 diabetes
title_fullStr The effect of fibroblast growth factors and advanced glycation end-products on the intima-media complex thickness in patients with coronary heart disease and type 2 diabetes
title_full_unstemmed The effect of fibroblast growth factors and advanced glycation end-products on the intima-media complex thickness in patients with coronary heart disease and type 2 diabetes
title_sort effect of fibroblast growth factors and advanced glycation end-products on the intima-media complex thickness in patients with coronary heart disease and type 2 diabetes
publisher Endocrinology Research Centre
publishDate 2014
url https://doaj.org/article/b9e0cb3b58644a6e8d6dd1d79c33d463
work_keys_str_mv AT ekaterinavladimirovnaivannikova theeffectoffibroblastgrowthfactorsandadvancedglycationendproductsontheintimamediacomplexthicknessinpatientswithcoronaryheartdiseaseandtype2diabetes
AT victoryurievichkalashnikov theeffectoffibroblastgrowthfactorsandadvancedglycationendproductsontheintimamediacomplexthicknessinpatientswithcoronaryheartdiseaseandtype2diabetes
AT olgamikhailovnasmirnova theeffectoffibroblastgrowthfactorsandadvancedglycationendproductsontheintimamediacomplexthicknessinpatientswithcoronaryheartdiseaseandtype2diabetes
AT alexanderborisovichkuznetsov theeffectoffibroblastgrowthfactorsandadvancedglycationendproductsontheintimamediacomplexthicknessinpatientswithcoronaryheartdiseaseandtype2diabetes
AT anatolievichterekhin theeffectoffibroblastgrowthfactorsandadvancedglycationendproductsontheintimamediacomplexthicknessinpatientswithcoronaryheartdiseaseandtype2diabetes
AT alexanderviktorovichilin theeffectoffibroblastgrowthfactorsandadvancedglycationendproductsontheintimamediacomplexthicknessinpatientswithcoronaryheartdiseaseandtype2diabetes
AT ekaterinavladimirovnaivannikova effectoffibroblastgrowthfactorsandadvancedglycationendproductsontheintimamediacomplexthicknessinpatientswithcoronaryheartdiseaseandtype2diabetes
AT victoryurievichkalashnikov effectoffibroblastgrowthfactorsandadvancedglycationendproductsontheintimamediacomplexthicknessinpatientswithcoronaryheartdiseaseandtype2diabetes
AT olgamikhailovnasmirnova effectoffibroblastgrowthfactorsandadvancedglycationendproductsontheintimamediacomplexthicknessinpatientswithcoronaryheartdiseaseandtype2diabetes
AT alexanderborisovichkuznetsov effectoffibroblastgrowthfactorsandadvancedglycationendproductsontheintimamediacomplexthicknessinpatientswithcoronaryheartdiseaseandtype2diabetes
AT anatolievichterekhin effectoffibroblastgrowthfactorsandadvancedglycationendproductsontheintimamediacomplexthicknessinpatientswithcoronaryheartdiseaseandtype2diabetes
AT alexanderviktorovichilin effectoffibroblastgrowthfactorsandadvancedglycationendproductsontheintimamediacomplexthicknessinpatientswithcoronaryheartdiseaseandtype2diabetes
_version_ 1718429553101111296